K

Katherine Nelson

Merck & Co., Inc., Rahway, NJ, USA (United States)

ORCID: 0000-0001-5197-5586

246 papers and 15.7k citations.

PubIndex Score98Top 2%How it's scored

246Publications

15.7kTotal Citations

First senior author: 1977

Top publicationsby citations

Strategies for implementing long‐acting cabotegravir for PrEP in US clinics serving Black women: interim healthcare provider findings from the EBONI study

Katherine Nelson, Nanlesta Pilgrim, Theo Hodge et al.|Journal of the International AIDS Society|2025

Cited by 4

P-1899. Improvement in Provider Experiences from Baseline to Month 12 with Integrating Cabotegravir Long-Acting (CAB LA) for PrEP into Care in an Implementation Science Trial (PILLAR)

Taimur Khan, Nanlesta Pilgrim, Jonathan M. L. White et al.|Open Forum Infectious Diseases|2025

Cited by 0

Indexing the rest of 246 publications…